Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2006
A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype
Sarah L Rea, John P Walsh, Lynley Ward, et al.
Journal of Cellular Physiology
|
May 5, 2007
Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL)
Estabelle S M Ang, Ping Zhang, James H Steer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 13, 2015
Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis
Xiang Zhu, Junjie Gao, Pei Y Ng, et al.
Journal of Leukocyte Biology
|
January 10, 2016
Src family kinase expression and subcellular localization in macrophages: implications for their role in CSF-1-induced macrophage migration
Amy R Dwyer, Kellie A Mouchemore, James H Steer, et al.
Biochemical Pharmacology
|
February 25, 2016
Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo
Xiang Zhu, Jun J Gao, Euphemie Landao-Bassonga, et al.
Journal of Cellular Biochemistry
|
October 29, 2011
Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK
Estabelle S M Ang, Nathan J Pavlos, Shek Man Chim, et al.
The Journal of Biological Chemistry
|
March 27, 2009
Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis
HaoTian Feng, Taksum Cheng, James H Steer, et al.
Journal of Cellular Physiology
|
August 15, 2009
Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity
Estabelle S M Ang, Nathan J Pavlos, Lee Y Chai, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 12, 2005
Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production
Kirk H M Yip, Ming H Zheng, James H Steer, et al.
Frontiers in Immunology
|
March 6, 2026
The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity
Michael W Murrey, Ashleigh R Poh, James H Steer, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2006
A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype
Sarah L Rea, John P Walsh, Lynley Ward, et al.
Journal of Cellular Physiology
|
May 5, 2007
Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL)
Estabelle S M Ang, Ping Zhang, James H Steer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 13, 2015
Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis
Xiang Zhu, Junjie Gao, Pei Y Ng, et al.
Journal of Leukocyte Biology
|
January 10, 2016
Src family kinase expression and subcellular localization in macrophages: implications for their role in CSF-1-induced macrophage migration
Amy R Dwyer, Kellie A Mouchemore, James H Steer, et al.
Biochemical Pharmacology
|
February 25, 2016
Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo
Xiang Zhu, Jun J Gao, Euphemie Landao-Bassonga, et al.
Journal of Cellular Biochemistry
|
October 29, 2011
Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK
Estabelle S M Ang, Nathan J Pavlos, Shek Man Chim, et al.
The Journal of Biological Chemistry
|
March 27, 2009
Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis
HaoTian Feng, Taksum Cheng, James H Steer, et al.
Journal of Cellular Physiology
|
August 15, 2009
Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity
Estabelle S M Ang, Nathan J Pavlos, Lee Y Chai, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 12, 2005
Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production
Kirk H M Yip, Ming H Zheng, James H Steer, et al.
Frontiers in Immunology
|
March 6, 2026
The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity
Michael W Murrey, Ashleigh R Poh, James H Steer, et al.
Page
of 6